reviewTop 1% cited
Role of epidermal growth factor receptor in breast cancer
Breast Cancer Research and Treatment · 2012 · Vol. 136(2) · pp. 331–345
Hiroko Masuda(The University of Texas MD Anderson Cancer Center)Dongwei Zhang(The University of Texas MD Anderson Cancer Center)Chandra Bartholomeusz(The University of Texas MD Anderson Cancer Center)Hiroyoshi Doihara(Okayama University Hospital)Gabriel N. Hortobágyi(The University of Texas MD Anderson Cancer Center)Naoto T. Ueno✉(The University of Texas MD Anderson Cancer Center)
HER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesEpidermal growth factor receptorChemosensitizerBreast cancerTriple-negative breast cancerMedicineCancer researchEGFR inhibitorsTargeted therapyOncologyCancer
MeSH terms
Antineoplastic AgentsBreast NeoplasmsClinical Trials as TopicFemaleHumansReceptors, EstrogenReceptors, ProgesteroneNeoplasms, Basal CellErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-2Protein Kinase InhibitorsEpithelial-Mesenchymal TransitionInflammatory Breast NeoplasmsMolecular Targeted TherapyErbB Receptors
Citations
786
FWCI
11.49
field-weighted impact
References
94
Percentile
99%
vs. same field & year
Citations per year
Cited by
Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
International Journal of Molecular Sciences · 2017 · 1,300 citations
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
Cancers · 2020 · 330 citations
Prediction and investigation of prognostic factors, therapeutic targets from medicinally significant plant for breast cancer
Journal of Pharmacognosy and Phytochemistry · 2024 · 0 citations
References
Prognostic markers in triple‐negative breast cancer
Cancer · 2006 · 1,276 citations
The epidermal growth factor receptor family: Biology driving targeted therapeutics
Cellular and Molecular Life Sciences · 2008 · 756 citations
Epithelial-mesenchymal transition and its implications for fibrosis
Journal of Clinical Investigation · 2003 · 2,289 citations
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
New England Journal of Medicine · 2004 · 11,455 citations
The EGF receptor family as targets for cancer therapy
Oncogene · 2000 · 1,342 citations
Epithelial–mesenchymal transitions in tumour progression
Nature reviews. Cancer · 2002 · 6,649 citations
Molecular portraits of human breast tumours
Nature · 2000 · 16,173 citations
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Journal of Clinical Investigation · 2011 · 5,405 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
